
MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 14, 2026.
Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.
| Revenue (TTM) | $15.32B |
| Gross Profit (TTM) | $3.09B |
| EBITDA | $657.96M |
| Operating Margin | 7.96% |
| Return on Equity | 34.30% |
| Return on Assets | 4.47% |
| Revenue/Share (TTM) | $53.60 |
| Book Value | $6.66 |
| Price-to-Book | 4.93 |
| Price-to-Sales (TTM) | 0.64 |
| EV/Revenue | 0.422 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 125.60% |
| Quarterly Revenue Growth (YoY) | 70.40% |
| Shares Outstanding | $273.47M |
| Float | $263.10M |
| % Insiders | 5.24% |
| % Institutions | 73.77% |
Volatility is currently expanding

MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 14, 2026.

MTCH, PBI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 12, 2026.

The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.

Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Oscar Health, Inc. (OSCR) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to a loss of $0.89 per share a year ago.

Health insurer Oscar Health swung to a $361 million second quarter profit while eclipsing $1 billion in net income for the first six months of the year as health plan membership rose and medical costs eased.

NEW YORK--(BUSINESS WIRE)--Oscar Health announces strong 2Q 2026 results with significant year-over-year improvement across all core metrics.

SANM, OSCR and PENN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6th, 2026.

Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OSCR and any ticker you trade — then tracks every position and per-strategy win rate.